is investigating potential claims on behalf of investors of Apyx Medical Corporation (“Apyx”) ( NASDAQ: APYX ) pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Investors have 60 days from April 17, 2019 to move the Court to serve as lead plaintiff in the securities class action lawsuit. If you are an APYX shareholder who has suffered losses, please click Join a …